Leonard S. Schleifer
2018
In 2018, Leonard S. Schleifer earned a total compensation of $26.5M as President and Chief Executive Officer at Regeneron Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,953,710 |
|---|---|
| Option Awards | $21,339,913 |
| Salary | $1,330,500 |
| Other | $896,432 |
| Total | $26,520,555 |
Schleifer received $21.3M in option awards, accounting for 80% of the total pay in 2018.
Schleifer also received $3M in non-equity incentive plan, $1.3M in salary and $896.4K in other compensation.
Rankings
In 2018, Leonard S. Schleifer's compensation ranked 79th out of 14,244 executives tracked by ExecPay. In other words, Schleifer earned more than 99.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 79 out of 14,244 | 99th |
Division Manufacturing | 21 out of 5,765 | 100th |
Major group Chemicals And Allied Products | 7 out of 2,128 | 100th |
Industry group Drugs | 5 out of 1,817 | 100th |
Industry Pharmaceutical Preparations | 3 out of 1,391 | 100th |
Source: SEC filing on April 26, 2019.
Schleifer's colleagues
We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2018.
2018
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2018
Marion McCourt
Regeneron Pharmaceuticals
Senior Vice President, Commercial
2018
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2018
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019